1Division Gynecologic Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA;
2Department of Public Health, Harvard School of Public Health, Massachusetts Cancer Registry, Boston, MA;
3Department of Medicine, Boston University School of Medicine, Boston, MA;
4Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and
5Department of Obstetrics and Gynecology, Boston Medical Center, Boston University School of Medicine, Boston, MA
Reprint requests to: Sarah Feldman, MD, MPH, Division of Gynecologic Oncology, Brigham and Women's Hospital, 75 Francis Street, ASB3-1, Boston, MA 02115. E-mail: [email protected]
S.F. and J.H. received funding from National Cancer Institute at the National Institutes of Health (1UM1CA221940). E.C. has received training grant funding from the National Institutes of Health (Grants R25 CA 98566-10, T32 CA 009001-40, and T32 ES 007069). R.P. has received funding from the American Cancer Society (RSG-15-150-01). The authors acknowledge the Centers for Disease Control and Prevention for its financial support under Cooperative Agreement 1 NU58DP006271-01-00 awarded to the Massachusetts Cancer Registry, Massachusetts Department of Public Health.
Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.
Key points: Cervical cancer rates remained high in women age 65 and older.
